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Abstract
Resistance to β-lactam/β-lactamase inhibitors in enterobacteria is a growing problem 
that has not been intensively studied in Argentina.
In the present work, 54/843 enterobacteria collected in a teaching hospital of Buenos 
Aires city were ampicillin-sulbactam-resistant isolates remaining susceptible to second- 
and third-generation cephalosporins. The enzymatic mechanisms present in the isolates, 
which were also amoxicillin-clavulanic acid (AMC)-resistant (18/54) were herein analyzed.
Sequencing revealed two different variants of blaTEM-1, being blaTEM-1b the most frequently 
detected allelle (10 Escherichia coli, 3 Klebsiella pneumoniae, 2 Proteus mirabilis and 
1 Raoultella terrigena) followed by blaTEM-1a (1 K. pneumoniae). Amoxicillin-clavulanate 
resistance seems to be mainly associated with TEM-1 overproduction (mostly in E. coli) 
or co-expressed with OXA-2-like and/or SHV β-lactamases (K. pneumoniae and 
P. mirabilis).
A new blaTEM variant (TEM-163) was described in an E. coli strain having an AMC MIC value 
of 16/8 μg/ml. TEM-163 contains Arg275Gln and His289Leu amino acid substitutions. On the 
basis of the high speciÀ c activity and low IC50 for clavulanic acid observed, the resistance 
pattern seems to be due to overproduction of the new variant of broad spectrum 
β-lactamase rather than to an inhibitor-resistant TEM (IRT)-like behavior.
© 2014 Asociación Argentina de Microbiología. Published by Elsevier España, S.L. All 
rights reserved.
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Introduction
Amoxicillin-clavulanate (AMC) is one of the most frequently 
prescribed antibiotic combinations in many countries, espe-
cially in ambulatory patients. For this reason, even if it is 
still a low occurrence event, resistance to β-lactam/
β-lactamase inhibitors among enterobacteria clinical isola-
tes is an emerging worldwide problem. Different enzymatic 
mechanisms are associated with AMC resistance: hyperpro-
duction of chromosome-encoded class C β-lactamases, 
acquired plasmid-encoded cephalosporinases (AmpC type), 
hyperproduction of plasmid-mediated class A β-lactamases 
(such as TEM-1 and SHV-1 enzymes), production of class D 
oxacillinases and inhibitor-resistant TEM (IRTs or CMTs) and 
SHV mutants6,14,19,23 (whose β-lactamase activities are poorly 
inhibited by clavulanate). In addition to enzymatic mecha-
nisms, a decrease in the expression or absence of outer 
membrane proteins might also be involved, i.e., a deÀ cien-
cy in the OmpF and/or OmpC production has been associa-
ted to this phenotype in Escherichia coli4.
IRTs were frequently described as plasmid-encoded enzy-
mes derived from TEM-1 or TEM-2 β-lactamases and detec-
ted mainly from European isolates. Substitutions of one or 
more amino-acid residues at positions 69, 244, 275 and 276 
render structural changes in β-lactamases that affect afÀ ni-
ty for inhibitors, but produce only slight modiÀ cations in 
the isoelectric point (pI) or activity on other β-lactam com-
pounds. Other substitutions also found in IRT β-lactamases 
do not seem to be involved in the IRT phenotype9.
Overproduction of both TEM-1 and SHV-1, or production 
of an IRT may increase resistance to amoxycillin, ticarcillin, 
amoxicillin-clavulanic acid and, frequently to piperacillin 
and ticarcillin-clavulanic acid, while only slightly affecting 
susceptibility to narrow spectrum cephalosporins, cepha-
mycins, extended-spectrum cephalosporins, and, in most 
cases, to piperacillin-tazobactam3.
Over the last years, an increase in the rate of resistance 
to AMC has been noted among E. coli isolates in our country. 
According to the “Sistema Informático de Resistencia (SIR)” 
susceptibility to ampicillin-sulbactam in E. coli has been 
decreasing from 62%22 (years 2004-2005) to 50% (years 2006-
2008; M. Radice, personal communication). In spite of the 
high use of this association, there is little information avai-
lable about the prevalence of AMC resistance mechanisms 
in Enterobacteriaceae.
The aim of this study was to investigate the enzymatic 
mechanisms of amoxicillin-clavulanate-resistant entero-
bacteria lacking inducible chromosomal ampC genes isola-
ted from a teaching hospital of Buenos Aires city.
Materials and methods
Microorganisms
Isolates recovered from different clinical specimens that 
fulÀ lled a screening criteria (Enterobacteriaceae resistant 
to ampicillin-sulbactam but remaining susceptible to ce-
foxitin, ceftazidime and cefotaxime by a disk diffusion me-
thod) were studied. Isolates were collected within a 5-month 
period (May to September 2008) from patients attending 
the Hospital de Clínicas that belongs to UBA (University of 
ş-lactamasas producidas por enterobacterias resistentes a amoxicilina-ácido 
clavulánico aisladas en Buenos Aires, Argentina: un nuevo gen blaTEM
Resumen
La resistencia a la combinación de β-lactámico/inhibidor de β-lactamasa en enterobac-
terias es un problema creciente que no ha sido estudiado intensamente en Argentina.
En el presente trabajo, 54/843 enterobacterias recolectadas en un hospital universitario 
de la ciudad de Buenos Aires fueron resistentes a ampicilina-sulbactama, pero se mantu-
vieron sensibles a las cefalosporinas de segunda y tercera generación. Se analizaron los 
mecanismos enzimáticos presentes en los aislamientos que también fueron resistentes a 
amoxicilina-ácido clavulánico (AMC) (18/54).
La secuenciación reveló dos variantes diferentes de blaTEM-1, donde blaTEM-1b es el alelo más 
frecuentemente detectado (10 Escherichia coli, 3 Klebsiella pneumoniae, 2 Proteus mi-
rabilis y 1 Raoultella terrigena), seguidos por blaTEM-1a (1 K. pneumoniae). La resistencia 
a AMC parece estar asociada principalmente con la hiperproducción de TEM-1 (sobre todo 
en E. coli) o con la coexpresión con β-lactamasas tipo OXA-2 y/o SHV (K. pneumoniae y 
P. mirabilis).
Se describió una nueva variante de blaTEM (TEM-163) en un aislamiento de E. coli que 
presentó una CIM frente a AMC de 16/8 μg/ml. La enzima TEM-163 contiene dos sustitu-
ciones de aminoácidos respecto de TEM-1, Arg275Gln y His289Leu. Teniendo en cuenta la 
alta actividad especíÀ ca observada y la baja IC50 para el ácido clavulánico, el patrón de 
resistencia de este aislamiento parece obedecer a la hiperproducción de la nueva varian-
te de la β-lactamasa de amplio espectro, en lugar de vincularse con un comportamiento 
similar al de una TEM resistente a inhibidores (IRT).
© 2014 Asociación Argentina de Microbiología. Publicado por Elsevier España, S.L. Todos 
los derechos reservados.
PALABRAS CLAVE
Resistencia a 
amoxicilina-ácido 
clavulánico; 
TEM-163;
Enterobacteria; 
Hiperproducción 
de TEM-1
212 J.A. Di Conza et al 
Buenos Aires) “José de San Martín”, Buenos Aires, Argenti-
na.
E. coli ATCC 35218, TEM-1 basal level producer, was used 
as reference.
Susceptibility testing
Antimicrobial susceptibility testing was performed using 
the disk diffusion method and the agar dilution method as 
described by the Clinical Laboratory Standard Institute 
(CLSI). Results were interpreted accordin g to the CLSI gui-
delines2. Tested antibiotics were ampicillin (AMP), ampici-
llin-sulbactam (AMS), Amoxicillin-clavulanic acid (AMC), pi-
peracillin (PIP), piperacillin/tazobactam (PTZ), cephalothin 
(CTN), cefoxitin (FOX), ceftriaxone (CRO), ceftazidime 
(CAZ), cefepime (FEP), imipenem (IMP), meropenem (MER), 
ertapenem (ERT), amikacin (AMI), gentamicin (GEN), po-
lymyxin B (POL), trimethoprim-sulfamethoxazole (TMS), ci-
proÁ oxacin (CIP), nitrofurantoin (NIT). AMS and AMC MICs 
were tested at a 2:1 À xed ratio. Antimicrobial agents tested 
and reported were obtained from Britania S.A. (disks) and 
Klonal laboratorios (drugs), Argentina.
ş-lactamase assays
Cells were harvested by centrifugation from overnight LB 
broth cultures and resuspended in 0.5 ml of sodium phospha-
te buffer (0.1 M, pH 7). β-lactamases were released by so-
nication (ten 1-min high-frequency discontinuous bursts on 
ice at output 4-5 and duty cycle: 50%) using SonicVibra Cell 
ultrasonic processor (Sonics & Materials Inc., USA).
Isoelectric focusing was performed with crude extracts 
applied to polyacrylamide gels (pH gradient 3-10) in an LKB 
2117-Multiphor II isoelectric focusing tank (LKB Produkter 
AB, Sweden), as previously described15. β-Lactamase activi-
ty was revealed by the agar iodometric system using AMP 
(500 mg/l) as substrate, as previously described25. TEM-1 (pI 
5.4), SHV-2 (pI 7.6), OXA-2 (pI 7.7) and CTX-M-2 (pI 8.2) 
producing strains were used as standards and were run si-
multaneously with the samples. 
Semi-quantiÀ cation of β-lactamase production was de-
termined as described below: total protein concentration in 
crude enzyme preparations was determined by the Bradford 
method (Bio-Rad Laboratories, USA), adjusted at the same 
protein concentration and diluted with 100 mM sodium 
phosphate buffer (pH 7.0). β-Lactamase activity of each en-
zymatic extract and decimal dilutions (20 μl) were evalua-
ted using the iodometric method employing AMP as substra-
te. Clinical isolates that showed β-lactamase activity in 
dilutions higher than the reference strain were considered 
enzyme overproducers.
SpeciÀ c activity was determined in those isolates harbo-
ring β-lactamases that focused at pI 5.4. This activity was 
measured three times per strain by the spectrophotometric 
assay using nitroceÀ n (482 nm) as substrate at a À nal con-
centration of 100 μM. TEM-1 overproduction was arbitrarily 
deÀ ned when speciÀ c activity was at least two-fold higher 
than E. coli ATCC 35218. 
Inhibition studies were performed by measuring the resi-
dual β-lactamase activity of crude extracts previously pre-
incubated with clavulanic acid (0.1, 1 and 10 μM) for 15 min 
at room temperature. IC50 was deÀ ned as the clavulanic 
acid concentration required to inhibit 50% of the β-lactamase 
activity.
Detection of blaTEM, blaSHV and blaOXA genes
Molecular detection of blaTEM, blaSHV and blaOXA-1, blaOXA-2 and 
blaOXA-10 group was carried out by PCR ampliÀ cation using 
speciÀ c primers (Table 1). The reaction mixture contained 2 
μl of total heat extracted DNA as template, and 1.25 U of 
T-free DNA polymerase (Inbio Highway, Argentina) was 
added to a total volume of 50 μl containing 0.2 mM deoxy-
nucleoside triphosphate, 20 mM Tris-HCl (pH 8.4), 1.5 mM 
MgCl2, 50 mM KCl, and 0.5 μM primers. The reaction proto-
col required an initial step of 5 min at 95°C, followed by 
30 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 
1 min, with a À nal extension at 72°C for 20 min. E. coli 
ATCC 35218, K. pneumoniae ATCC 700603, Salmonella 
Infantis S215 and Enterobacter cloacae 15321 strains were 
used as positive controls. 
Sequencing of the blaTEM genes
PCR products were puriÀ ed using either the GFX™ PCR DNA 
or Gel Band PuriÀ cation Kit (Amersham Biosciences, Pisca-
Table 1 PCR primers used to detect β-lactamase genes and the expected amplicon sizes
Oligonucleotide name Sequence 5´→3´ Expected size (bp) Reference
TEM-F TAACCCTGGTAAATGCTTCA 940 This study
TEM-R CAATCTAAAGTATATATGAG This study
SHV-GF ATGCGTTWTDTTCGCCKGTG 861 This study
SHV-GR TTAGCGTTGCCAGTGCTCGAT This study
OXA-1F CCATTATTTGAAGGAACTGA 720 This study
OXA-1R TAGTGTGTTTAGAATGGTGA This study
OXA-2A CCTGCATCGACATTCAAGATA 460 5
OXA-2B CTCAACCCATCCTACCCACCA 5
OXA-10F GCCATGAAAACATTTGCCGC 801 21
OXA-10R GCCACCAATGATGCCCTCAC 21
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taway, NJ, USA). blaTEM sequences were performed on an ABI 
377 DNA sequencer (Perkin Elmer, Applied Biosystems). The 
nucleotide sequences and their derived amino acid sequen-
ces were compared to previously described sequences ob-
tained from the GenBank database and β-lactamase classi-
À cation in Lahey website (http://www.lahey.org/Studies/), 
respectively. Sequences were aligned using Vector NTI Suite 
9 program (InforMax, Inc.). 
Molecular epidemiology
The genetic relationship between the-AMC-resistant E. coli 
isolates was determined by REP-PCR.
Nucleotide accession numbers
The nucleotide sequence of a novel variant of blaTEM gene 
(blaTEM-163) was deposited in the GenBank database under ac-
cession number EU815939.
Results
Susceptibility testing
Fifty-four (6.4%) out of a total of 843 documented 
infections were caused by different Enterobacteriaceae 
that fulÀ lled the proposed selection criterion. These 
bacteria, lacking inducible chromosomal AmpC genes, 
were: 38 E. coli, 8 K. pneumonia, 5 P. mirabilis, 2 K. oxytoca 
and 1 Raoultella terrigena, and displayed MIC values of 
AMS higher than 16/8 μg/ml.
As not all AMS-resistant isolates are also AMC-resis-
tant16,18; therefore, AMC susceptibility was À rst determined 
by the agar disk diffusion method. Taking this feature into 
account, 18/54 (33.3%) isolates were À nally selected to 
characterize the β-lactamase/s involved: 7 of them were 
clearly AMC-resistant with inhibition zone diameters 
<14 mm (2 E. coli, 1 R. terrigena, 2 K. pneumoniae and 
2 P. mirabilis), 8 had intermediate susceptibility (all E. coli, 
with inhibition zone diameters between 14-17 mm) and 3 
had border line susceptibility (1 E. coli and 2 K. pneumoniae, 
inhibition zone = 18 mm).
Resistance proÀ les were further explored by MIC deter-
mination to a large set of antibiotics. Relevant results are 
shown in Table 2. All of them were sensitive to FOX but PIP 
and CTN susceptibility was variable. All isolates remained 
susceptible to PTZ, extended-spectrum cephalosporins 
(CRO, CAZ, FEP) and carbapenems (IMP, MER, ERT) tested 
(data not shown). Thus, chromosomal or plasmid AmpC 
hyper-producing and CMT-producing isolates were ruled 
out.
Regarding susceptibility to non β-lactam antibiotics, 9/
11 E. coli were resistant to TMS, 4/11 to CIP and 3/11 to 
NIT; 4/4 K. pneumoniae were resistant to TMS and NIT, 2/4 
were resistant or had intermediate susceptibility to GEN 
and AMK, and 1/4 was resistant to CIP; and À nally 2/2 
P. mirabilis were resistant to GEN and NIT, and 1/2 was 
resistant to CIP. Except for natural resistance in P. mirabilis, 
all isolates were susceptible to POL.
Table 2 Species, specimens and MIC determinations for eighteen selected isolates
MIC (μg/ml)
Strain Species Specimen AMP AMC PIP CTN FOX
2772 E. coli urine 1024 16/8 32 16 1 
3184 E. coli urine ≥1024 32/16 512 64 4 
3637 E. coli urine ≥1024 16/8 512 64 4 
3313 E. coli urine ≥1024 16/8 256 32 2 
41002 E. coli blood ≥1024 32/16 1024 ≥64 2 
2754 E. coli urine ≥1024 32/16 256 64 2 
3317 E. coli urine ≥1024 16/8 128 64 2 
40952 E. coli blood ≥1024 16/8 256 8 1 
3343 E. coli urine ≥1024 16/8 128 32 2 
40479 E. coli blood ≥1024 16/8 128 32 4 
2617 E. coli urine 1024 16/8 64 32 4 
2574 R. terrigena urine ≥1024 16/8 1024 ≥64 4 
2875 K. pneumoniae urine ≥1024 16/8 1024 ≥64 1 
3400 K. pneumoniae urine 1024 16/8 16 8 4 
41362 K. pneumoniae blood 512 32/16 16 2 2
41318 K. pneumoniae blood ≥1024 32/16 512 64 2 
1130 P. mirabilis bone ≥1024 64/32 32 32 8 
1132 P. mirabilis wound ≥1024 64/32 32 64 8
AMP, ampicillin; AMC, amoxicillin-clavulanic acid; PIP, piperacillin; CTN, cephalothin; FOX, cefoxitin.
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Resistance mechanisms
All crude extracts showed β-lactamase activity when analy-
zed by the iodometric assay employing AMP as substrate. 
Characterization of the β-lactamases revealed that all ex-
tracts possessed, at least, an enzyme that focused at pI 5.4 
and 7/18 co-produced other enzymes that focused at diffe-
rent pI (Table 3). Ten of eleven E. coli isolates only displa-
yed the pI 5.4 enzyme.
All isolates were positive for blaTEM and PCR products 
were sequenced subsequently. Variants of the blaTEM-1 
gene were detected, being blaTEM-1b described in 16 isolates. 
The blaTEM-1a allele was only noted in one K. pneumoniae 
strain (Table 3) and no other variants of blaTEM-1 gene were 
detected. An E. coli isolate (strain 3343) produced a new 
variant of the blaTEM gene (named blaTEM-163), which differed 
from blaTEM-1b in 3 bp (see below for more details).
When tested for other β-lactamase genes by PCR, only 
one E. coli, three K. pneumoniae and two P. mirabilis isola-
tes were positive for blaOXA-2-group genes (Table 3). The 
blaSHV gene was only detected in all K. pneumoniae isolates. 
Not a single isolate rendered a positive ampliÀ cation for 
blaOXA-1 or blaOXA-10 group. These results agreed with pI values 
previously obtained. 
Most isolates that only harbored the blaTEM-1 determinant 
(7 E. coli and 1 R. terrigena) showed a higher level of TEM-1 
production, and could be considered as probable 
TEM-1 overproducers since they showed an enzyme produc-
tion 2-12-fold higher than E. coli ATCC 35218 (Table 3). The 
remaining two E. coli strains, with intermediate susceptibi-
lity to AMC, displayed a basal or slightly increased level of 
TEM-1, suggesting that other mechanisms would be involved 
in the susceptibility decrease observed. Results achieved by 
the spectrophotometer method were coincident with those 
obtained by the iodometric semi-quantitative assay.
E. coli 3343, in which the new TEM-163 was present, also 
showed a proÀ le compatible with TEM overproduction (with 
a speciÀ c activity that was 6-fold higher than E. coli ATCC 
35218). In this case, IC50 values for clavulanic acid were si-
milar to t he IC50value measured on the reference TEM-1-
producing strain (IC50 around of 1μM). Because of these cha-
racteristics, rather than thinking of TEM-163 as a probable 
IRT β-lactamase, the AMC-resistance phenotype is likely due 
to overproduction of this new β-lactamase.
As expected from isolates that were mostly obtained 
from urine samples with no strong epidemiological link, 
even those producing only a TEM β-lactamase, the different 
E. coli isolates are assumed as the different clones displayed 
a dissimilar banding proÀ le by REP-PCR (data not shown).
TEM-163 versus TEM-122
TEM-163-producing E. coli was resistant to AMP, AMS 
(MIC32/16 μg/ml), PIP and CTN, of intermediate suscepti-
bility to AMC (MIC=16/8 μg/ml) and susceptible to FOX (Ta-
ble 2). The blaTEM-163 gene presents more than 99% identity 
Table 3 Ch aracterization of β-lactamases produced by studied isolates 
Strains β-lactamase 
productiona
pI PCR results Sequence of 
blaTEM gene
Phenotype
X ± SD blaTEM blaSHV blaOXA-2
2772 2.10 ± 0.06 5.4 + - - blaTEM-1b TEM-1 overproducer 
3184 3.16 ± 0.55 5.4 + - - blaTEM-1b TEM-1 overproducer
3637 1.81 ± 0.08 5.4 + - - blaTEM-1b TEM-1 producer
3313 2.50 ± 0.44 5.4 + - - blaTEM-1b TEM-1 overproducer
41002 4.44 ± 0.53 5.4 + - - blaTEM-1b TEM-1 overproducer
2754 3.15 ± 0.52 5.4 + - - blaTEM-1b TEM-1 overproducer
3317 1.27 ± 0.17 5.4 + - - blaTEM-1b TEM-1 producer 
40952 2.88 ± 0.42 5.4 + - - blaTEM-1b TEM-1 overproducer 
3343 6.14 ± 1.42 5.4 + - - blaTEM-163 TEM-163 overproducer
40479 3.16 ± 1.61 5.4 + - - blaTEM-1b TEM-1 overproducer
2617 ND 5.4 - § 7.2 + - + blaTEM-1b TEM-1 + OXA-2-like
2574 12.02 ± 4.02 5.4 + - - blaTEM-1b TEM-1 overproducer
2875 ND 5.4 - § 7.2 - >8 + + + blaTEM-1b TEM-1 + SHV-like + OXA-2-like
3400 ND 5.4 - § 7.2 + + - blaTEM-1a TEM-1 + SHV-like
41362 ND 5,4 - § 7.6 + + + blaTEM-1b TEM-1 + SHV-like + OXA-2-like
41318 ND 5.4 - § 7.6 + + + blaTEM-1b TEM-1 + SHV-like + OXA-2-like
1130 ND 5.4 - § 7.2 + - + blaTEM-1b TEM-1 + OXA-2-like
1132 ND 5.4 - § 7.2 + - + blaTEM-1b TEM-1 + OXA-2-like
a Expressed as the ratio of speciÀ c activity between each strain vs E. coli ATCC 35218 (β-lactamase activity average = 121.1 nmol/
min.mg). ND: not determined.
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with blaTEM-122 (previously considered IRT)
10. blaTEM-122 variant 
(accession number AY307100) could be considered a 
blaTEM-1b-derived gene that has a G→A transition at base 
812, leading to Arg→Gln amino acid change at position 275 
(numbering according to Ambler et al.1). A new mutation 
(A→T transversion) at base 854 was detected in blaTEM-163 
producing a His→Leu amino acid substitution at position 
289 in the mature protein of TEM-163, which has not been 
previously reported (Table 4). Distinctiveness of these mu-
tations was veriÀ ed by sequencing both the coding and non-
coding strands from two independent PCR reactions.
Discussion
We have focused the study on β-lactamases present in di-
fferent Enterobacteriaceae with phenotypic resistance to 
β-lactam/β-lactamase inhibitors but remaining susceptible 
to cefoxitin and extended-spectrum cephalosporins. During 
the 5-month period of our study the overall frequency of 
ampicillin-sulbactam-resistant isolates (all non-inducible 
AmpC producing enterobacteria) remained at about 6.4%. 
Among them, we selected those that also showed a reduced 
inhibition zone to AMC by the disk diffusion test to describe 
the enzymatic mechanisms that are poorly known in our 
country. AMC resistance in Enterobacteriaceae is a complex 
phenomenon with heterogeneous clinical implications.
The overproduction of TEM-like enzymes followed by 
TEM-1 production in combination with OXA-2-type and/or 
SHV-type β-lactamases were the main mechanisms identi-
À ed. 
In agreement with literature data, genes encoding TEM-1 
were detected in the majority of the isolates examined, 
being blaTEM-1b the predominant allelic variant (16/18) 
identiÀ ed so far, and only one blaTEM-1a harboring strain 
(K. pneumonia 3400) was described. Consistently, other 
blaTEM-1 variants (i.e. blaTEM-1c, blaTEM-1d, blaTEM-1e), rarely 
detected in enterobacteria13,17, were not found.
The presumed overproduction of TEM-1 β-lactamase in 
E. coli, which was present in 7/11 isolates with reduced 
susceptibility to AMC, was the main mechanism responsible 
for that resistance proÀ le. These data are similar to those 
detected in E. coli by Pérez-Moreno et al. in Spain20, although 
other researchers have observed a lower proportion19,24. 
At least two mechanisms may lead to TEM overproduc-
tion: 1- multiple copies of the blaTEM gene due to the pre-
sence of multiple copies of a plasmid per cell have been 
reported to cause overproduction of β-lactamase or, 2- di-
fferent promoter regions have been widely reported in va-
rious isolates. Even though blaTEM-1a and blaTEM-1b alleles were 
initially associated with a weak promoter7 (called P3), it is 
known that stronger promoters could be present (i.e., Pa/
Pb, P4, P5) upstream of blaTEM-like genes, which would ex-
plain the higher levels of production of TEM enzymes11-13.
Two E. coli isolates producing a basal or slightly increased 
level of TEM-1 as a single resistance mechanism showed re-
duced susceptibility to AMC and CTN, being the reduced 
permeability or increased efÁ ux to β-lactam antibiotics the 
possible resistance mechanisms involved4,20.
In the present study, OXA-2-type enzymes were mainly 
associated with K. pneumoniae and P. mirabilis, while the 
OXA-1 and OXA-10 groups were not detected. OXA-2-like 
enzymes, known to be more poorly inhibited by clavulanic 
acid than class A β-lactamases, accounted for 33% (6/18) of 
the isolates analyzed, but when E. coli determinants were 
compared with other studies13,19,20,24, the frequency of OXA-
producing E. coli remained low (1/11). 
Genes encoding SHV-1 and other close related enzymes 
have been shown to be natural in K. pneumoniae chromoso-
me9; therefore blaSHV detection in this species is always ex-
pectable.
Contribution of IRT β-lactamases to AMC resistance in 
Enterobacteriaceae appear to be different in isolates from 
diverse countries. In this study, IRT-like enzymes were not 
detected among isolates having intermediate susceptibility 
and also among those that were clearly resistant. To the 
best of our knowledge, the presence of IRT-producing isola-
tes appears to be much less common in the American conti-
nent than in Europe14. Nevertheless, ampliÀ cation and di-
rect sequencing of blaTEM has contributed to discover a new 
enzymatic variant called TEM-163 present in an E. coli stra-
in having intermediate susceptibility to AMC (MIC= 
16/8 mg/l). The predicted amino acid sequence of the 
latter contained the same substitution present in TEM-12210 
(Arg275Gln), and also provided an extra mutation (His289Leu), 
which has not been previously described. 
An in silico model of TEM coevolution network and its 
communities was constructed by Guthrie et al., and the 
two mutant positions described in this work (275, 289) are 
included within the inhibitor-resistant β-lactamase commu-
nity. Interestingly, position 289 is located at the interface 
between the two communities8 (extended-spectrum and in-
hibitor resistance).
The amino acid substitution at position 275 (located at 
the C-terminal of the Ş-11 helix) was previously considered 
important to confer resistance to β-lactamase inhibitors. 
However, the same substitution (Arg275Gln) was involved in 
TEM-45 (IRT-14), TEM-82 and TEM-83 but these enzymes 
contained at least a second mutation in residue 6910,13, 
which was highly associated with IRT enzymes3,9.
The absence of a mutation in residue 69 on this new 
β-lactamase in agreement with its low IC50 to clavulanic 
Table 4 Nucleotide mutations and amino acid 
substitutions in E. coli isolate encoding new β-lactamase
Position and character of altered basea 
(amino acid)b in the coding region of the 
blaTEM gene
blaTEM gene 18 228 396 812 
(275)
854 
(289)
blaTEM-1a C C G G(Arg) A (His)
blaTEM-1b T T T G(Arg) A(His)
blaTEM-122 C T T A(Gln) A (His)
blaTEM-163 C T T A(Gln) T (Leu)
The sequences are compared to those of blaTEM-1a and 
blaTEM-1b.
a Numbering according to start codon.
b Numbering according to Ambler et al.1.
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acid allow us to speculate that TEM-163 is more clearly a 
new variant of broad spectrum β-lactamase than an IRT en-
zyme (IC50>10 μM is considered a probable IRT enzyme
20). In 
conclusion, amoxicillin-clavulanate resistance in different 
species of non-inducible AmpC Enterobacteriaceae isolated 
in a teaching hospital from Buenos Aires seems to be mainly 
associated with TEM-1 overproduction or TEM-1, OXA-2-like 
and/or SHV-like β-lactamase co-production. 
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